Mosaic ImmunoEngineering (CPMV) Change in Acquisitions & Divestments (2010 - 2019)
Mosaic ImmunoEngineering (CPMV) posted quarterly Change in Acquisitions & Divestments of $500000.0 for Q4 2019, little changed quarter-over-quarter from $500000.0 in Q3 2019.
Mosaic ImmunoEngineering (CPMV) Change in Acquisitions & Divestments (2010 - 2019) Analysis & Trends
Mosaic ImmunoEngineering's Change in Acquisitions & Divestments history runs 10 years deep, the most recent figure standing at $500000.0 for Q4 2019.
- In Q4 2019, Change in Acquisitions & Divestments changed N/A year-over-year to $500000.0; the TTM figure through May 2020 stood at $1.0 million (changed N/A YoY), while the FY2020 annual figure was $1.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q4 2019 stood at $500000.0, roughly flat from $500000.0 in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $1.8 million in Q1 2018, with the low at $500000.0 in Q1 2015.
- The 5-year median for Change in Acquisitions & Divestments is $700000.0 (2016), against an average of $784375.0.
- The sharpest annual moves came in 2015 and 2017: Change in Acquisitions & Divestments tumbled 47.43% in 2015, then jumped 190.0% in 2017.
- Mosaic ImmunoEngineering's Change in Acquisitions & Divestments stood at $750000.0 in 2015, then plunged by 33.33% to $500000.0 in 2016, then surged by 190.0% to $1.4 million in 2017, then slumped by 51.72% to $700000.0 in 2018, then retreated by 28.57% to $500000.0 in 2019.
- Business Quant data shows CPMV's Change in Acquisitions & Divestments at $500000.0 in Q4 2019, $500000.0 in Q3 2019, and $700000.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2019 | 500,000.00 |
| Nov 30, 2019 | 500,000.00 |
| Aug 31, 2019 | 500,000.00 |
| Aug 31, 2019 | 500,000.00 |
| May 31, 2018 | 700,000.00 |
| May 31, 2018 | 700,000.00 |
| Feb 28, 2018 | 1.75 Mn |
| Feb 28, 2018 | 1.75 Mn |
| Nov 30, 2017 | 1.45 Mn |
| Nov 30, 2017 | 1.45 Mn |
| Aug 31, 2017 | 1.00 Mn |
| Aug 31, 2017 | 1.00 Mn |
| May 31, 2017 | 750,000.00 |
| May 31, 2017 | 750,000.00 |
| Feb 28, 2017 | 1.20 Mn |
| Feb 28, 2017 | 1.20 Mn |
| Nov 30, 2016 | 500,000.00 |
| Nov 30, 2016 | 500,000.00 |
| Aug 31, 2016 | 750,000.00 |
| Aug 31, 2016 | 750,000.00 |